BRAFAlterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549-Reference-Cited by-同舟云学术

BRAFAlterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549

Published:2012-01 Issue:1 Volume:71 Page:66-72
ISSN:0022-3069
Container-title:Journal of Neuropathology & Experimental Neurology
language:en
Short-container-title:J Neuropathol Exp Neurol

Author:

Lin Alex,Rodriguez Fausto J.,Karajannis Matthias A.,Williams Susan C.,Legault Genevieve,Zagzag David,Burger Peter C.,Allen Jeffrey C.,Eberhart Charles G.,Bar Eli E.

Publisher

Oxford University Press (OUP)

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Neurology,General Medicine,Pathology and Forensic Medicine

Reference30 articles.

1. Population-Based Studies on Incidence, Survival Rates, and Genetic Alterations in Astrocytic and Oligodendroglial Gliomas

2. CBTRUS . Primary Brain Tumors in the United States, 2000–2004. Hinsdale, IL: Central Brain Tumor Registry of the United States, 2008

3. Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literature

4. Comprehensive genomic characterization defines human glioblastoma genes and core pathways

5. Frequent Gains at Chromosome 7q34 Involving BRAF in Pilocytic Astrocytoma

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of KIAA1549::BRAF fusions and clinicopathological insights of pilocytic astrocytomas;Annals of Diagnostic Pathology;2024-10

2. Integral neuro-oncological diagnosis As the basis for personalized treatment Of brain tumors (on the example of gliomas In children);Translational Medicine;2024-03-13

3. A case of a pilocytic astrocytoma with histological features of anaplasia and unprecedent genetic alterations;Neuropathology;2023-10

4. Hairy cell leukaemia with an IGH–BRAF fusion gene;British Journal of Haematology;2023-07-11

5. Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy;Frontiers in Oncology;2023-06-15